Scheme

quant Mid Cap Fund

Holds 23 companies worth ₹6,641 Cr in Sept 2026.

Fund house
QUANTThe fund house that runs this scheme.
AUM
₹7,669 Crquant Mid Cap Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 4.7% on Aug 2026, ₹8,051 Cr.
Largest holding
Aurobindo PharmaAurobindo Pharma is 10.7% of this scheme's NAV.
Fund manager
Sandeep TandonRuns it since 3 Feb 2025, as the fund house dates it. With Sameer Kate (fund manager), Yug Tibrewal (fund manager), Ankit Pande (co-manager), Varun Pattani (co-manager), Ayusha Kumbhat (co-manager), Sanjeev Sharma (co-manager).

Overview^{(9 Oct 2026)}

Fund managers7

Sandeep TandonFund manager · Feb 2025 · 34y · MBA
Sameer KateFund manager · Mar 2025 · 21y · MBA
Yug TibrewalFund manager · Mar 2025 · 8y · CFA
Ankit PandeCo-manager · May 2023 · 14y · CFA MBA
Varun PattaniCo-manager · Feb 2025 · 4y · CA
Ayusha KumbhatCo-manager · Feb 2025
Sanjeev SharmaCo-manager · Sept 2026 · 21y · PGDM M.Com

Key facts

Benchmark: NIFTY MID CAP 150 TRI
Risk: Very High
Expense: Regular 2.21% · Direct 1.19%
Exit load: 0.5% within 3 months
Started: 36970
Minimum: ₹5,000

Source.Its Scheme Summary Document as of 9 Oct 2026 at AMFI.

What changed^{(0 changes)}

Nothing has changed in its documents since Sept 2026.

Source.Its filings at NSE, since Sept 2026.

Fund managers over time^{(May 2023 – now)}

MainCoSlice202420252026

Fig. 1.Who ran it when: each manager from the date the fund house gives, or the first document listing them where it gives none, to when they left. A slice is part of it: overseas, gold and silver, or arbitrage.

Costs^{(Oct 2026 – Oct 2026)}

Every change to the expense ratio, newest first.
1 filing	Regular	Direct	Δ pt
9 Oct 2026	2.21%	1.19%	–

Direct plan, 9 Oct 2026

1.19%

Regular plan 2.21% · Exit load 0.5% within 3 months

Fig. 1.Total expense ratio a year, each plan's, as its Scheme Summary Documents state it, filing by filing at NSE (none yet: today's, at AMFI). A change holds until the next.

Objective and risk^{(9 Oct 2026)}

Objective

The primary investment objective of the scheme is to generate capital appreciation & provide long-term growth opportunities by investing in a portfolio of Mid Cap companies. There is no assurance that the investment objective of the Scheme will be achieved.

Risk, type and benchmark

Riskometer: Very High
At launch: Moderately High
Type: An open ended equity scheme predominantly investing in Mid Cap Stocks
Benchmark: NIFTY MID CAP 150 TRI

Asset allocation it may hold% of NAV

Equity and equity related instruments of Mid cap companies(including units issued by REITs)
Allowed65–100%
Other equity and equity related instruments(including units issued by REITs)
Allowed0–35%
Debt & Money Market instruments
Allowed0–35%Holds13.2%
Units issued by InvITs
Allowed0–10%Holds0.0%

Holds in Sept 2026.86.8% equity · 13.2% debt and cash

How to invest^{(9 Oct 2026)}

Buying

To start: ₹5,000, then in multiples of ₹1
To add: ₹1,000, then in multiples of ₹1

Selling and switching

To redeem: ₹1 or No minimum redemption criterion for Unit based redemption units
Switch minimum: Switch - in: Rs. 5,000/- and in multiples of Re. 1/- thereafter. Switch-out: Rs. 1,000/-- or the unit balance whichever is less
Switch multiples: Re. 1

Scheme details^{(9 Oct 2026)}

What it is

Category: Mid Cap Fund
Offer: 36934 to 36948
Started: 36970
Reopened: 36971
Plans: 1. quant Mid Cap Fund Growth Option - Regular Plan · 2. quant Mid Cap Fund Growth Option - Direct Plan · 3. quant Mid Cap Fund IDCW Option - Regular Plan · 4. quant Mid Cap Fund IDCW Option - Direct Plan
Face value: ₹10
Listed: No

How it is run

Swing pricing: No
Side-pocketing: No
Custodian: HDFC Bank Limited
Auditor: M/s. M M Nissim & Co. LLP
Registrar: KFin Technologies Limited
SEBI code: QNTM/O/E/MIF/01/02/0003